Cargando…

Zespół łamliwego Chromosomu x i Choroby FMR1-zależne - Objawy Kliniczne, Epidemiologia i Podłoże Molekularne Choroby

Fragile X syndrome (FXS) is the second most common inherited cause of intellectual disability (ID), after Down syndrome. The severity of ID in FXS patients varies and depends mainly on the patient’s sex. Besides intellectual disorders, additional symptoms, such as psychomotor delay, a specific behav...

Descripción completa

Detalles Bibliográficos
Autores principales: Landowska, Aleksandra, Rzońca, Sylwia, Bal, Jerzy, Gos, Monika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sciendo 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522919/
https://www.ncbi.nlm.nih.gov/pubmed/29641417
http://dx.doi.org/10.34763/devperiodmed.20182201.1421
_version_ 1784585184854671360
author Landowska, Aleksandra
Rzońca, Sylwia
Bal, Jerzy
Gos, Monika
author_facet Landowska, Aleksandra
Rzońca, Sylwia
Bal, Jerzy
Gos, Monika
author_sort Landowska, Aleksandra
collection PubMed
description Fragile X syndrome (FXS) is the second most common inherited cause of intellectual disability (ID), after Down syndrome. The severity of ID in FXS patients varies and depends mainly on the patient’s sex. Besides intellectual disorders, additional symptoms, such as psychomotor delay, a specific behavioral phenotype, or emotional problems are present in FXS patients. In over 99% of the cases, the disease is caused by the presence of a dynamic mutation in the FMR1 gene localized on the X chromosome. Due to the expansion of CGG nucleotides (over 200 repeats), FMR1 gene expression is decreased and results in the significant reduction of the FMRP protein level. The CGG expansion to premutation range (55-200 CGG repeats) is equivalent to the FXS carrier status and may cause FMR1-dependent disorders − fragile X-associated primary ovarian insufficiency (FXPOI) and fragile X-associated tremor/ataxia syndrome (FXTAS). In contrast to FXS, clinical symptoms of these diseases occur later in adulthood. The aim of the article is to present the knowledge about the molecular background and epidemiology of fragile X syndrome and other FMR1-related disorders.
format Online
Article
Text
id pubmed-8522919
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Sciendo
record_format MEDLINE/PubMed
spelling pubmed-85229192021-11-19 Zespół łamliwego Chromosomu x i Choroby FMR1-zależne - Objawy Kliniczne, Epidemiologia i Podłoże Molekularne Choroby Landowska, Aleksandra Rzońca, Sylwia Bal, Jerzy Gos, Monika Dev Period Med Original articles/Prace oryginalne Fragile X syndrome (FXS) is the second most common inherited cause of intellectual disability (ID), after Down syndrome. The severity of ID in FXS patients varies and depends mainly on the patient’s sex. Besides intellectual disorders, additional symptoms, such as psychomotor delay, a specific behavioral phenotype, or emotional problems are present in FXS patients. In over 99% of the cases, the disease is caused by the presence of a dynamic mutation in the FMR1 gene localized on the X chromosome. Due to the expansion of CGG nucleotides (over 200 repeats), FMR1 gene expression is decreased and results in the significant reduction of the FMRP protein level. The CGG expansion to premutation range (55-200 CGG repeats) is equivalent to the FXS carrier status and may cause FMR1-dependent disorders − fragile X-associated primary ovarian insufficiency (FXPOI) and fragile X-associated tremor/ataxia syndrome (FXTAS). In contrast to FXS, clinical symptoms of these diseases occur later in adulthood. The aim of the article is to present the knowledge about the molecular background and epidemiology of fragile X syndrome and other FMR1-related disorders. Sciendo 2018-04-12 /pmc/articles/PMC8522919/ /pubmed/29641417 http://dx.doi.org/10.34763/devperiodmed.20182201.1421 Text en © 2018 Aleksandra Landowska, Sylwia Rzońca, Jerzy Bal, Monika Gos, published by Sciendo https://creativecommons.org/licenses/by/4.0/This work is licensed under the Creative Commons Attribution 4.0 International License.
spellingShingle Original articles/Prace oryginalne
Landowska, Aleksandra
Rzońca, Sylwia
Bal, Jerzy
Gos, Monika
Zespół łamliwego Chromosomu x i Choroby FMR1-zależne - Objawy Kliniczne, Epidemiologia i Podłoże Molekularne Choroby
title Zespół łamliwego Chromosomu x i Choroby FMR1-zależne - Objawy Kliniczne, Epidemiologia i Podłoże Molekularne Choroby
title_full Zespół łamliwego Chromosomu x i Choroby FMR1-zależne - Objawy Kliniczne, Epidemiologia i Podłoże Molekularne Choroby
title_fullStr Zespół łamliwego Chromosomu x i Choroby FMR1-zależne - Objawy Kliniczne, Epidemiologia i Podłoże Molekularne Choroby
title_full_unstemmed Zespół łamliwego Chromosomu x i Choroby FMR1-zależne - Objawy Kliniczne, Epidemiologia i Podłoże Molekularne Choroby
title_short Zespół łamliwego Chromosomu x i Choroby FMR1-zależne - Objawy Kliniczne, Epidemiologia i Podłoże Molekularne Choroby
title_sort zespół łamliwego chromosomu x i choroby fmr1-zależne - objawy kliniczne, epidemiologia i podłoże molekularne choroby
topic Original articles/Prace oryginalne
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522919/
https://www.ncbi.nlm.nih.gov/pubmed/29641417
http://dx.doi.org/10.34763/devperiodmed.20182201.1421
work_keys_str_mv AT landowskaaleksandra zespołłamliwegochromosomuxichorobyfmr1zalezneobjawykliniczneepidemiologiaipodłozemolekularnechoroby
AT rzoncasylwia zespołłamliwegochromosomuxichorobyfmr1zalezneobjawykliniczneepidemiologiaipodłozemolekularnechoroby
AT baljerzy zespołłamliwegochromosomuxichorobyfmr1zalezneobjawykliniczneepidemiologiaipodłozemolekularnechoroby
AT gosmonika zespołłamliwegochromosomuxichorobyfmr1zalezneobjawykliniczneepidemiologiaipodłozemolekularnechoroby